Prescribing Information

 

SPIRIVA® Respimat® (tiotropium) for severe asthma

SPIRIVA® Respimat® (tiotropium) for severe asthma

SPIRIVA (tiotropium) Respimat inhaler device with cap removed while releasing solution into the air plus logo and male patient

SPIRIVA® Respimat® (tiotropium)
for severe asthma

SPIRIVA® Respimat® is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma who experienced one or more severe asthma exacerbations in the preceding year.

About severe asthma
Meet your patient
LAMA (tiotropium) in severe asthma
Why SPIRIVA® Respimat®?
Respimat resources
SPIOLTO (Tiotropium + olodaterol) Respimat inhaler device with cap removed while releasing solution into the air plus logo and female patient

SPIOLTO® Respimat® (tiotropium + olodaterol) for COPD

SPIOLTO® Respimat® is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD.

Meet your patients
LAMA + LABA (tiotropium + olodaterol)
Switching from a LAMA
SMI or DPI?
Respimat resources

COPD, chronic obstructive pulmonary disease; LAMA, long-acting muscarinic receptor antagonist; LABA, long-acting beta agonist; DPI, dry powder inhaler; SMI, soft mist inhaler.

PC-GB-108822 V2

April 2024

Reporting adverse events

Adverse events should be reported. Reporting form and information can be found atwww.mhra.gov.uk/yellowcard. Adverse events should also be reported to Boehringer Ingelheim Drug Safety on0800 328 1627 (freephone).

Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.